Herceptin injection 60, manufactured by Chugai Pharmaceutical, contains Trastuzumab (genetical recombination), an anti-HER2 humanized monoclonal antibody used to treat HER2-positive breast and gastric cancers, and advanced salivary gland cancer. It is supplied as 60mg 1 bottle and has YJ code 4291406D5024.
Herceptin injection 60
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).